Skip to content

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02354378
Enrollment
84
Registered
2015-02-03
Start date
2012-08-31
Completion date
2015-03-31
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dexmedetomidine, Memory

Brief summary

The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in children has not been studied.

Interventions

DRUGDexmedetomidine

Sponsors

Memorial Sloan Kettering Cancer Center
CollaboratorOTHER
Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* The patient must be between 4 and 14 yrs of age and be undergoing a therapeutic or diagnostic procedure with or without sedation * The patient must be able to comprehend and perform the task (naming pictures) * The patient must have a minimum weight of 8 kg

Exclusion criteria

* Allergy to Dexmedetomidine (for those patients requiring sedation) * Procedure of short duration (\< 15 min) * Pregnancy * Recent use (within 5 half-lives) of centrally acting medications that could affect concentration (e.g. diphenhydramine)

Design outcomes

Primary

MeasureTime frameDescription
Sedation ThresholdUntil the child has reviewed cards and is under sedation or for the control group has reviewed 100 cardsDuring the 10-minute bolus infusion of Dexmedetomidine, children will be presented with pictures at 5-second intervals and asked to name the picture. They will be asked to name each picture (e.g., cat, tree, pencil, etc.). A valid response is naming of the picture within 5 seconds, either correctly or incorrectly.The important response measure is whether the child is awake enough to perform the naming task.

Secondary

MeasureTime frameDescription
Memory ThresholdUntil 100 cards have been presented to the child. Approx. 10 minutes.At the presentation of each picture, the child will be asked whether or not he/she remembers having seen it previously. Each response will be coded as correct (true positives and true negatives) or incorrect (false positives and false negatives)

Countries

United States

Participant flow

Participants by arm

ArmCount
Children Undergoing Sedation With Dexmedetomidine
Children who will undergo sedation for MRI will be given a memory encoding task during dexmedetomidine bolus induction to measure the effects of sedation. The mere task of naming a picture will encode that picture into memory. When the anesthesia has worn off (at approximately 1 hour later), children will be given a memory recognition task to measure the amnesic effects of dexmedetomidine. Dexmedetomidine Memory Test
30
Children Not Undergoing Sedation
A control group of children of similar age scheduled for MRI will be recruited to perform memory recognition testing. Memory Test
16
Total46

Baseline characteristics

CharacteristicChildren Not Undergoing SedationChildren Undergoing Sedation With DexmedetomidineTotal
Age, Categorical
<=18 years
16 Participants30 Participants46 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous9.5 years
STANDARD_DEVIATION 1.9
6.1 years
STANDARD_DEVIATION 1.2
7.7 years
STANDARD_DEVIATION 2.2
Region of Enrollment
United States
16 Participants30 Participants46 Participants
Sex: Female, Male
Female
8 Participants22 Participants30 Participants
Sex: Female, Male
Male
8 Participants8 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 640 / 20
serious
Total, serious adverse events
0 / 640 / 20

Outcome results

Primary

Sedation Threshold

During the 10-minute bolus infusion of Dexmedetomidine, children will be presented with pictures at 5-second intervals and asked to name the picture. They will be asked to name each picture (e.g., cat, tree, pencil, etc.). A valid response is naming of the picture within 5 seconds, either correctly or incorrectly.The important response measure is whether the child is awake enough to perform the naming task.

Time frame: Until the child has reviewed cards and is under sedation or for the control group has reviewed 100 cards

ArmMeasureValue (MEAN)Dispersion
Children Undergoing Sedation With DexmedetomidineSedation Threshold26.8 Number of Memory CardsStandard Deviation 7.9
Children Not Undergoing SedationSedation Threshold38.9 Number of Memory CardsStandard Deviation 5.9
Secondary

Memory Threshold

At the presentation of each picture, the child will be asked whether or not he/she remembers having seen it previously. Each response will be coded as correct (true positives and true negatives) or incorrect (false positives and false negatives)

Time frame: Until 100 cards have been presented to the child. Approx. 10 minutes.

ArmMeasureValue (MEAN)Dispersion
Children Undergoing Sedation With DexmedetomidineMemory Threshold35.1 Number of Memory Cards seen before scanStandard Deviation 6.6
Children Not Undergoing SedationMemory Threshold50 Number of Memory Cards seen before scanStandard Deviation 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026